Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Journal Article

    Shrestha Bhattarai, T.; Shamu, T.; Gorelick, A. N.; Chang, M. T.; Chakravarty, D.; Gavrila, E. I.; Donoghue, M. T. A.; Gao, J.; Patel, S.; Gao, S. P.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
    Journal Article

    Stover, E. H.; Xiong, N.; Myers, A. P.; Tayob, N.; Engvold, V.; Polak, M.; Broaddus, R. R.; Makker, V.; Drapkin, R.; Liu, J. F.; more...
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
    Journal Article

    Crowley, F.; Cadoo, K. A.; Chiang, S.; Mandelker, D. L.; Bajwa, R.; Iasonos, A.; Zhou, Q. C.; Miller, K. M.; Hensley, M. L.; O'Cearbhaill, R. E.
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
    Review

    Motzer, R. J.; Taylor, M. H.; Evans, T. R. J.; Okusaka, T.; Glen, H.; Lubiniecki, G. M.; Dutcus, C.; Smith, A. D.; Okpara, C. E.; Hussein, Z.; more...
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials
    Journal Article

    VanderWalde, N.; Moughan, J.; Lichtman, S. M.; Jagsi, R.; Ballo, M.; VanderWalde, A.; Mohiuddin, M.; Meropol, N. J.; Kachnic, L.; Berger, A.; more...
    Journal of Geriatric Oncology (2022)

    Fulltext@MSK | Save
  • Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: A resting state fMRI study
    Journal Article

    Vachha, B. A.; Gohel, S.; Root, J. C.; Kryza-Lacombe, M.; Hensley, M. L.; Correa, D. D.
    Brain Imaging and Behavior (2022)

    Fulltext@MSK | Save
  • Validation of a population-based data source to examine national cancer clinical trial participation
    Journal Article

    Green, A. K.; Tabatabai, S. M.; Bai, X.; Mishra Meza, A.; Lesny, A. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Salner, A, ; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Risk factors for hospitalizations among older adults with gastrointestinal cancers
    Journal Article

    Li, D.; Sun, C. L.; Allen, R.; Crook, C. J.; Levi, A.; Ballena, R.; Klepin, H. D.; Elias, R.; Mohile, S. G.; Tew, W. P.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: An NRG Oncology trial
    Journal Article

    Powell, M. A.; Filiaci, V. L.; Hensley, M. L.; Huang, H. Q.; Moore, K. N.; Tewari, K. S.; Copeland, L. J.; Secord, A. A.; Mutch, D. G.; Santin, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
    Journal Article

    Schöffski, P.; Tan, D. S. W.; Martín, M.; Ochoa-de-Olza, M.; Sarantopoulos, J.; Carvajal, R. D.; Kyi, C.; Esaki, T.; Prawira, A.; Akerley, W.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save